As we continue to deal with the COVID-19 pandemic, providing exceptional and safe care to our patients remains our No. 1 priority. Our faculty and hospital leadership continue to monitor and assess the current COVID-19 situation, and our action plan evolves daily.
Our providers believe in advancing pediatric medicine through the translation of novel research into cutting edge patient care and training of young physicians and scientists.
The only ACGME-accredited pediatric rheumatology training program in the state of Florida. We produce pediatric rheumatologists who will impact the future of clinical care and innovative research for children living with rheumatologic conditions.
We provide comprehensive clinical services and a collaborative team approach to the diagnosis and management of children with autoimmune diseases.
Our Pediatric Allergy program provides a broad range of clinical and diagnostic services to infants, children, and adolescents, as well as some select adult patients, with acute and chronic allergic disorders.
UF Pediatric News
A national committee that includes a prominent University of Florida physician has recommended to federal and world leaders a four-phase approach to fairly allocate COVID-19 vaccines when they become available.
Barry Byrne, M.D., Ph.D., receives “See The Light” Award from the Mathew Forbes Romer Foundation
While many experts are focused on identifying COVID-19 cases and slowing transmission, one UF research team is focused on the pandemic’s fallout on children and households.
Dr. Jennifer Co-Vu, a pediatric cardiologist at UF Health Shands Hospital, said people tend to think of the coronavirus in terms of mortality as opposed to morbidity. As some children…